Navigation Links
Sanofi Pasteur Presents Additional Data on Investigational Quadrivalent Influenza Vaccine
Date:10/21/2011

ne each year, making it possible to immunize more than 500 million people across the globe. A world leader in the vaccine industry, Sanofi Pasteur offers the broadest range of vaccines protecting against 20 infectious diseases. The company's heritage, to create vaccines that protect life, dates back more than a century. Sanofi Pasteur is the largest company entirely dedicated to vaccines. Every day, the company invests more than EUR 1 million in research and development. For more information, please visit: www.sanofipasteur.com or www.sanofipasteur.us

Forward Looking Statements This press release contains forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995, as amended. Forward-looking statements are statements that are not historical facts. These statements include projections and estimates and their underlying assumptions, statements regarding plans, objectives, intentions and expectations with respect to future financial results, events, operations, services, product development and potential, and statements regarding future performance. Forward-looking statements are generally identified by the words "expects", "anticipates", "believes", "intends", "estimates", "plans" and similar expressions. Although Sanofi's management believes that the expectations reflected in such forward-looking statements are reasonable, investors are cautioned that forward-looking information and statements are subject to various risks and uncertainties, many of which are difficult to predict and generally beyond the control of Sanofi, that could cause actual results and developments to differ materially from those expressed in, or implied or projected by, the forward-looking information and statements. These risks and uncertainties include among other things, the uncertainties inherent in research and development, future clinical
'/>"/>

SOURCE Sanofi Pasteur
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Vical Licensee Sanofi-aventis Initiates Phase 3 Trial to Reduce Amputations
2. Sanofi Pasteur Receives FDA Approval of Meningococcal Vaccine for Children
3. Sanofi Pasteur Initiates Phase II Trial of Cell Culture-Based Seasonal Influenza Vaccine
4. Sanofi Pasteur to Donate 60 Million Doses of H5N1 Vaccine to WHO Over 3 Years for its Influenza Vaccine Global Stockpile
5. Sanofi Pasteur Shipping First Doses of Influenza Vaccine for the 2008-2009 Season in the US
6. Insulin Analogues From Novo Nordisk, Eli Lilly and Sanofi-Aventis Will Drive Growth in the Type 1 Diabetes Drug Market
7. Sanofi Aventis: People With Type 2 Diabetes Treated With LANTUS(R) and APIDRA(R) Achieved Greater Reductions in A1C Than Those Treated With Pre-mixed Insulin
8. Sanofi Pasteur Starts a Phase II Study of a Vaccine Against Clostridium Difficile
9. Sanofi Pasteur Dengue Vaccine Enters Pediatric Efficacy Clinical Study
10. Sanofi-aventis Stands Behind the Safety of Lantus(R)
11. Sanofi Pasteur Submits Supplemental Application for A(H1N1) Pandemic Vaccine to U.S. FDA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/1/2015)... -- Following yesterday,s release of Center for Medicaid and Medicare ... you need to know: ... government programs. , ... parts of Medicare and other government programs because it relies ... prescription drug benefits to enrollees. , Competition and rebates ...
(Date:5/1/2015)... PLEASANTON, Calif. , May 1, 2015  Thoratec Corporation ... support therapies to save, support and restore failing hearts, announced ... the newly created role of President, International. This ... all Thoratec commercial operations outside of North America ... Asia , and Latin America , ...
(Date:5/1/2015)... May 1, 2015  Legendary actor and director ... new PBAFacts campaign designed to educate and encourage patients ... about Pseudobulbar Affect (PBA) and to speak with their ... actor has the ability to cry and laugh on ... control experienced by people living with PBA episodes. ...
Breaking Medicine Technology:5 Things to Know About the CMS Part D Data Release 25 Things to Know About the CMS Part D Data Release 3Thoratec Announces Addition To Senior Management Team 2Thoratec Announces Addition To Senior Management Team 3Danny Glover Joins PBA Facts Campaign, to Educate and Build Awareness of Pseudobulbar Affect (PBA), a Little Known but Widespread Neurologic Condition 2Danny Glover Joins PBA Facts Campaign, to Educate and Build Awareness of Pseudobulbar Affect (PBA), a Little Known but Widespread Neurologic Condition 3
... Nov. 15, 2010 Spherix Incorporated (Nasdaq: ... diabetes and the metabolic syndrome, and a provider of ... and pharmaceutical companies, today reported results for the three ... and Upcoming Highlights Pharmaceutical Development ...
... 15, 2010 /PRNewswire-- Sangart, Inc., a global ... designed to enhance the perfusion and oxygenation of ... other gas delivery, today announced that its investigational ... designation by the U.S. Food and Drug Administration ...
Cached Medicine Technology:Spherix Announces Third Quarter 2010 Financial Results 2Spherix Announces Third Quarter 2010 Financial Results 3Spherix Announces Third Quarter 2010 Financial Results 4Spherix Announces Third Quarter 2010 Financial Results 5Spherix Announces Third Quarter 2010 Financial Results 6Sangart, Inc. Receives U.S. Orphan Drug Designation for use of MP4CO in Patients with Sickle Cell Disease 2Sangart, Inc. Receives U.S. Orphan Drug Designation for use of MP4CO in Patients with Sickle Cell Disease 3
(Date:5/1/2015)... 2015 The fields of genetics and ... interplay of genes with one another and the environment, ... daunting. , LabRoots, the premier producer of interactive virtual ... soon host its annual conference spotlighting the recent advances ... Genetics and Genomics 2015 , a two-day event presented ...
(Date:5/1/2015)... Today the United Nations Foundation’s Girl Up campaign announced that ... the rights of adolescent girls in India. This announcement ... Up began almost five years ago – kicks off a ... the Rajasthan region of India. , “For the past ... girls in Guatemala, Ethiopia, Liberia, and Malawi. As we ...
(Date:5/1/2015)... 01, 2015 Digital technology and Wi-Fi-enabled ... women between prenatal appointments, a preliminary study ... small sample of low-risk pregnant women, will be presented ... University Medical Faculty Associates at the 2015 American Congress ... Meeting, May 2-6. The digital technology used was developed ...
(Date:5/1/2015)... On May 5 the frozen yogurt chain ... Mayo with a twist. The new Cinco de Froyo ... one 24 ounce frozen yogurt for $5.55 at participating stores. ... 1862 in commemoration of a Mexican victory over the French. ... States, but events are also held in such distant locales ...
(Date:5/1/2015)... in five Americans suffer from at least one type ... With warmer weather hitting a majority of the country, ... sixth edition of "Allergies and Asthma," a guide for ... triggers, manage symptoms and enjoy springtime. , "Thanks ... , everyone has friends or family members who are ...
Breaking Medicine News(10 mins):Health News:Recent Advances in Genetics and Genomics: A BioConference Live 2015 Virtual Event 2Health News:Recent Advances in Genetics and Genomics: A BioConference Live 2015 Virtual Event 3Health News:United Nations Foundation’s Girl Up Campaign Announces New Funding Initiative to Support Adolescent Girls in India 2Health News:United Nations Foundation’s Girl Up Campaign Announces New Funding Initiative to Support Adolescent Girls in India 3Health News:Mobile Technology May Be Effective in Monitoring Pregnant Women Between Office Visits, Study Shows 2Health News:Mobile Technology May Be Effective in Monitoring Pregnant Women Between Office Visits, Study Shows 3Health News:sweetFrog to Celebrate Cinco de Mayo with a Yogurt Twist 2Health News:Living a Life Without Limits Through Mediaplanet’s Allergies and Asthma Campaign 2
... also repair damaged ankles claim the researchers. ,Arthroscopy ... but it is also a valuable method for treating ... technique it is being applied in new ways by ... damage, bone chips and recurrent pain from end-stage arthritis. ...
... disease, is becoming an elite disease as so much of ... As a result of such ongoing research, hyperhomocysteinemia (increased levels ... the risk factors.// ,Dr. O Mayer Jr and colleagues ... result of their study that beer may provide enough folate--a ...
... strike a pot of gold by making cheap anti-AIDS ... likely to escalate in coming days. ,The large ... develop anti-AIDS drugs and market it in India and ... anti-AIDS drug market, currently dominated by Mumbai-based Cipla, witnessed ...
... health"- this warning , printed in every cigarette carton ,had been ... many. But now the fact that even a single cigarette is ... of North Carolina. ,It is a well known fact that ... as heart attack , cancer etc.,. Dr. Firas A. ...
... improve mood and reduce fatigue, study reports. ,It is a ... asset. But as far as mental fatigue is concerned, there was ... based on the preliminary findings which included 14 women who did ... benefits as far as mood is concerned. ,Cheryl J. Hansen ...
... Crohn's disease and ulcerative colitis, often grouped together ... of modern, industrialized nations with stringent standards of ... prevents the human immune system from interacting with ... to develop properly...Yes! Doctors at the University of ...
Cached Medicine News:Health News:Arthroscopy for Ankles 2Health News:WORM! WORM! all the way 2
Combined Screen (RNP, Sm, Jo-1, Scl-70, SS-A, SS-B) ELISA kit....
... Scientific, Inc. ENA Screen ELISA test system ... detect antibodies to extractable nuclear antigens (anti-ENA) ... the directional insert, this test system is ... for, such as those against Jo-1, Sm, ...
... Single Well Screening Kit is designed to screen ... autoantibodies. Each microtiter well is coated with Sm, ... allows the laboratory to cost effectively screen out ... the ENA specificity on any of the company's ...
The K-ASSAY Rheumatoid Factor Control Set is intended to be used as a consistent test sample of known concentration for monitoring the performance of K-ASSAY immunoturbidimetric assay for quantifying...
Medicine Products: